Calton & Associates Inc. Makes New $494,000 Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Calton & Associates Inc. bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 5,487 shares of the exchange traded fund’s stock, valued at approximately $494,000.

A number of other institutional investors have also modified their holdings of XBI. OLD National Bancorp IN acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $450,000. Highland Capital Management LLC lifted its position in shares of SPDR S&P Biotech ETF by 10.4% in the 4th quarter. Highland Capital Management LLC now owns 25,509 shares of the exchange traded fund’s stock worth $2,297,000 after buying an additional 2,404 shares during the last quarter. Ibex Wealth Advisors acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $1,473,000. Masso Torrence Wealth Management Inc. grew its position in shares of SPDR S&P Biotech ETF by 3.0% during the 4th quarter. Masso Torrence Wealth Management Inc. now owns 27,017 shares of the exchange traded fund’s stock valued at $2,433,000 after buying an additional 796 shares during the last quarter. Finally, Tamar Securities LLC raised its stake in SPDR S&P Biotech ETF by 2.6% during the fourth quarter. Tamar Securities LLC now owns 42,602 shares of the exchange traded fund’s stock worth $3,837,000 after acquiring an additional 1,081 shares during the period.

SPDR S&P Biotech ETF Stock Up 1.0 %

Shares of XBI stock opened at $93.54 on Friday. The company has a market cap of $7.13 billion, a P/E ratio of 11.47 and a beta of 1.11. The business has a 50 day moving average of $93.31 and a two-hundred day moving average of $96.77. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.